BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2015
View Archived Issues
Novel conjugated vaccine shows greater protection against anthrax in mice
Read More
Hanmi initiates phase I trial of weekly-dosing formulation of basal insulin
Read More
Serendex to conduct phase II trial of inhaled GM-CSF in pneumonia-associated ARDS
Read More
VLPs show efficacy as pandemic avian influenza virus vaccines
Read More
BAY-94-9027 prophylaxis based on bleeding phenotype leads to greater control
Read More
New Bcl-2 inhibitors disclosed by Servier and Vernalis
Read More
Bayer divulges dual BRD4/PLK1 inhibitors
Read More
Actelion patents CXCR3 receptor antagonists
Read More
Janssen discloses new anti-HBV compounds
Read More
Polish and French team discloses 5-HT6 receptor antagonists
Read More
Actavis to divest Pharmatech to TPG
Read More
PEG-rFVIII shows safety and efficacy in hemophilia A patients
Read More
Small-sized Mucosolvan approved in Japan
Read More
Hospira launches first biosimilar MAb in major European markets
Read More
Galapagos reports promising phase I data for GLPG-1690
Read More
Dako and Ono Pharmaceutical to develop companion diagnostic test for Opdivo
Read More
Motesanib fails to achieve primary endpoint in phase III trial in NSCLC
Read More
FDA awards orphan drug designation to trofinetide for Rett syndrome
Read More
Molecular Templates recruits participants in phase I trial of MT-3724
Read More
Crown Bioscience acquires patient-derived xenograft models business from Molecular Response
Read More
CLS presents PK results of rFIX-albumin fusion protein
Read More
Great Basin begins clinical trial for Shiga toxin-producing E. coli diagnostic test
Read More
Hyperion Therapeutics enters into DiaPep277 agreements
Read More
FDA grants orphan drug status to RPC-4046 for eosinophilic esophagitis
Read More
Reolysin receives FDA orphan drug status for pancreatic cancer
Read More